The bar chart illustrates the proportion of total sales made by a pharmaceutical company in three regions the United States of America, Europe, and Asia between 2002 to 2006.
Overall, it can be seen from the graph in the five-year period, products were sold more in Asia and swelled as compared to the United States of America in 5 years, but exports declined every year and they became equal to Europe. Whereas in Europe the sales showed some fluctuations after it was downward trajectory in the final year.
It is conspicuous that the company sold 25% of medical products in 2002 and after that export continuously expanded to 35% in 2004 and reached 40% in 2006. Between 2002 to 2004 , the sale was augmented @5% each year except the year 2005, in that year it was 37%. Furthermore, initially, the company sold 41% products in the United States of America in 2002 and it experienced an abrupt plunge to 6% and touched 35% in 2003. Further, it fell dramatically to 27% in 2004, after that it started to expand regularly and attained 30% in 2006.
Probing ahead, the entity’s sales did not perform well in 2002 and it sold only 34% in Asia after that year it started to steadily increase to 38% in 2004, after that year it displayed a significant drop to 30% in 2006, before it was 34% in 2005.